UroGen Pharma (URGN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

URGN is expected to report earnings to fall 7.88% to -83 cents per share on November 12

UroGen Pharma URGN Stock Earnings Reports

Q3'24

Est.

$-0.84

Q2'24

Missed

by $0.08

Q1'24

Missed

by $0.10

Q4'23

Missed

by $0.04

Q3'23

Beat

by $0.17

The last earnings report on August 13 showed earnings per share of -91 cents, missing the estimate of -82 cents. With 377.02K shares outstanding, the current market capitalization sits at 543.27M.

View a ticker or compare two or three

Compare

URGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For URGN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for URGN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

400 Alexander Park Drive

Phone

+1 646 768-9780

Employees

201

Web

https://www.urogen.com